Cellular BIOtechnology for prognosis and monitoring in renal TRANSplantation

Project Information

TRANSBIO

Grant agreement ID: 733248

DOI 10.3030/733248

Project closed

EC signature date 26 September 2016

Start date 1 January 2017

End date 30 June 2019

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 3 846 640,86

EU contribution € 3 845 140,00

Coordinated by

BIOHOPE SCIENTIFIC SOLUTIONS FOR HUMAN HEALTH SL
Spain

Deliverables

Websites, patent fillings, videos etc. (1)

TRANSBIO webpage

A webpage (www.transbio.eu) will be prepared and updated in a 3 month basis.

Publications

Conference proceedings (6)

IMMUNOBIOGRAM A NEW IMMUNOLOGICAL TOOL TO PERSONALIZE IMMUNOSUPPRESSIVE THERAPY IN KIDNEY TRANSPLANT RECIPIENTS.

Author(s): Di Scala Marianna1, Portolés José Maria2, Jiménez Carlos3, Janeiro Dario2, González Elena3, Sánchez Sobrino Beatriz2, López Oliva María3, Richter Jose1, Ortega Álvaro1, Pascual Julio4, Portero Isabel1 1 BIOHOPE Scientific SL, Tres Cantos, Madrid, Spain, 2 Hospital Universitario Puerta de Hierro, Nephrology Department, Madrid, Spain 3 Hospital La Paz, Nephrology Department, Madrid, Spain
Published in: Abstract Book. BST18 – BASIC SCIENCE IN TRANSPLANTATION MEETING 2018, Issue Annual, 2018, Page(s) https://www.esot.org/events-education/events/11394/posters/2765
Publisher: European Society of Organ Transplantation

Immunobiogram: Patterns of resistance to immunomodulatory treatment in patients with chronic inflammatory diseases

Author(s): Ortega-Carrión Álvaro1, Di Scala Marianna1, Yebra Tatiana1, Diez Teresa 1, Richter Jose1, Portero Isabel1 1 BIOHOPE Scientific SL, Tres Cantos, Madrid, Spain
Published in: Abstracts Book, 5th European Congress of Immunology, 2-5 September Amsterdam, Issue Annual, 2018, Page(s) https://www.eci2018.org/fileadmin/user_upload/documents/ECI_2018_Abstract_Book_web_21082018.pdf
Publisher: European Federation of Immunological Societies (EFIS)

IMMUNOBIOGRAM a new immunological tool to personalize immunosuppressive therapy in kidney transplant recipients

Author(s): M. Di Scala1, J. Portolés2, C. Jiménez3, D. Janeiro2, E. González3, B. Sánchez Sobrino2, M. López Oliva3, J. Richter1, A. Ortega1, J. Pascual4, I. Portero1; 1 BIOHOPE Scientific SL, Madrid, Spain 2 Hospital Universitario Puerta de Hierro, Nephrology Department, Madrid, Spain, 3 Hospital La Paz, Nephrology Department, Madrid, Spain, 4 Hospital del Mar, Nephrology Department and Kidney Transpl
Published in: Abstracts Book, 5th European Congress of Immunology, 2-5 September Amsterdam, Issue Annual, 2018, Page(s) https://www.eci2018.org/fileadmin/user_upload/documents/ECI_2018_Abstract_Book_web_21082018.pdf
Publisher: European Federation of Immunological Societies (EFIS)

ANALYTICAL ROBUSTNESS AND CLINICAL CONSISTENCY EVALUATION OF A NEW IN VITRO DIAGNOSTIC BIOTECHNOLOGICAL IMMUNOASSAY TO HELP DECISION-MAKING IN ADJUSTMENT OF IMMUNOSUPPRESSANT THERAPY FOR KIDNEY TRANSPLANTATION: THE TRANSBIO STUDY

Author(s): Pascual, Julio ; Jimenez, Carlos ; Krajewska, Magdalena ; Kotton, Camile ; Seron, Daniel ; Portolés, Jose María ; Witzke, Oliver ; Sorensen, Soren S ; Andrés, Amado ; Díez, Teresa ; Ortega, Álvaro ; Portero, Isabel Hospital del Mar, Barcelona Spain ; Hospital La Paz, Madrid Spain ; Wroclaw Medical University Poland ; Massachusetts General Hospital, Boston United States ; Hospital Vall d’Heb
Published in: Abstract Book. ESOT 2019 – EUROPEAN SOCIETY OF ORGAN TRANSPLANTATION 2019, Issue Annual, 2019, Page(s) MP006
Publisher: European Society of Organ Transplantation

Immunobiogram, A New IVD Immunoassay To Test The Sensitivity Profile Of Kidney Transplant Recipients To Immunosuppressive Drugs: Further Results From BH-pilot Study

Author(s): Carlos Jiménez1, Jose María Portoles2, Daniel Blánquez3, Luis Arribas3, Álvaro Ortega4, Teresa Díez4, Isabel Portero4 on behalf of TRANSBIO STUDY GROUP 1 Hospital La Paz Madrid 2 Hospital Universitario Puerta de Hierro Madrid 3 Adamas Engineering Consulting, Madrid 4 BIOHOPE Scientific SL
Published in: Abstracts Book, 2019 American Transplant Congress, 01 – 05 Jun, 2019, Boston, Massachusetts, Issue Annual, 2019, Page(s) Control/Tracking Number: 19-A-3202-ATC
Publisher: American Transplant Congress

ECONOMIC EVALUATION OF AN IN VITRO DIAGNOSTIC ASSAY (IMMUNOBIOGRAM) IN THE SELECTION AND DOSE TITRATION OF IMMUNOSUPPRESSIVE THERAPY (IS) IN KIDNEY TRANSPLANT PATIENTS IN SPAIN

Author(s): Díez T1, Portero I1, Jimenez C2, Crespo M3, Portoles JM4, Rubio-Terrés 53, Rubio-Rodríguez D5. 1 Biohope, Madrid, Spain 2 Hospital La Paz, Nephrology Department, Madrid, Spain 3 Hospital del Mar, Nephrology Department and Kidney Transplantation, Barcelona, Spain 4 Hospital Puerta de Hierro, Nephrology Department, Madrid, Spain 5 Health Value, Madrid, Spain.
Published in: ISPOR Europe 2019 2-6 November 2019 | Copenhagen, Denmark, Issue ISPOR Abstract Book, 2019
Publisher: ISPOR Europe

Intellectual Property Rights

Patent (1)

METHOD FOR PREDICTING AND MONITORING CLINICAL RESPONSE TO IMMUNOMODULATORY THERAPY

Application/Publication number: EP 17382399
Date: 2017-06-26
Applicant(s): BIOHOPE SCIENTIFIC SOLUTIONS FOR HUMAN HEALTH SL

Trademark (1)

IMMUNOBIOGRAM

Application/Publication number: EU 15693716
Date: 2019-03-11
Applicant(s): BIOHOPE SCIENTIFIC SOLUTIONS FOR HUMAN HEALTH SL